AI-powered search

What is your recommended approach for managing patients who do not respond to ruxolitinib therapy for vitiligo?

Featuring Benjamin Lockshin, MD |

EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD

| Published July 01, 2024

Loading...

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved